Get started
Author

Xu Michael Di

Adriamycin-induced Senescence in Breast Tumor Cells Involves Functional p53 and Telomere Dysfunction
2002 · Lynne W. Elmore, Catherine W. Rehder, et al. · Journal of Biological Chemistry · 271
Evasion of a Single-Step, Chemotherapy-Induced Senescence in Breast Cancer Cells: Implications for Treatment Response
2005 · Lynne W. Elmore, Xu Di, et al. · Clinical Cancer Research · 151
PDF
Dual functions of autophagy in the response of breast tumor cells to radiation
2012 · Molly L. Bristol, Xu Di, et al. · Autophagy · 140
PDF
The Autophagy-Senescence Connection in Chemotherapy: Must Tumor Cells (Self) Eat Before They Sleep?
2012 · Rachel W. Goehe, Xu Di, et al. · Journal of Pharmacology and Experimental Therapeutics · 137
PDF
A Switch Between Cytoprotective and Cytotoxic Autophagy in the Radiosensitization of Breast Tumor Cells by Chloroquine and Vitamin D
2011 · Eden N. Wilson, Molly L. Bristol, et al. · Hormones and Cancer · 111
PDF
A novel cytostatic form of autophagy in sensitization of non-small cell lung cancer cells to radiation by vitamin D and the vitamin D analog, EB 1089
2014 · Khushboo Sharma, Rachel W Goehe, et al. · Autophagy · 96
PDF
Potentiation of radiation sensitivity in breast tumor cells by the vitamin D3 analogue, EB 1089, through promotion of autophagy and interference with proliferative recovery
2006 · Gerald DeMasters, Xu Di, et al. · Molecular Cancer Therapeutics · 83
Accumulation of autophagosomes in breast cancer cells induces TRAIL resistance through downregulation of surface expression of death receptors 4 and 5
2013 · Xu Di, Guofeng Zhang, et al. · Oncotarget · 79
PDF
Apoptosis, autophagy, accelerated senescence and reactive oxygen in the response of human breast tumor cells to Adriamycin
2009 · Xu Di, Robert P. Shiu, et al. · Biochemical Pharmacology · 76
Influence of the phosphodiesterase-5 inhibitor, sildenafil, on sensitivity to chemotherapy in breast tumor cells
2010 · Xu Di, Chris Gennings, et al. · Breast Cancer Research and Treatment · 63
FDA Approval Summary: Calaspargase Pegol-mknl For Treatment of Acute Lymphoblastic Leukemia in Children and Young Adults
2019 · Ruo-Jing Li, Runyan Jin, et al. · Clinical Cancer Research · 59
A chemotherapy-associated senescence bystander effect in breast cancer cells
2008 · Xu Di, Andrew Taylor Bright, et al. · Cancer Biology & Therapy · 57
PDF
Mislocalization of death receptors correlates with cellular resistance to their cognate ligands in human breast cancer cells
2012 · Jun-Jie Chen, H.-C. Jennifer Shen, et al. · Oncotarget · 52
PDF
Influence of p53 and caspase 3 activity on cell death and senescence in response to methotrexate in the breast tumor cell
2004 · Deepali K. Hattangadi, Gerald A. DeMasters, et al. · Biochemical Pharmacology · 52
Erythropoietin Fails to Interfere with the Antiproliferative and Cytotoxic Effects of Antitumor Drugs
2006 · David A. Gewirtz, Xu Di, et al. · Clinical Cancer Research · 51
Autophagy, cell death and sustained senescence arrest in B16/F10 melanoma cells and HCT-116 colon carcinoma cells in response to the novel microtubule poison, JG-03-14
2012 · Jonathan W. Biggers, Tuyen Nguyen, et al. · Cancer Chemotherapy and Pharmacology · 33
H-Ras regulation of TRAIL death receptor mediated apoptosis
2014 · Jun-Jie Chen, William P. Bozza, et al. · Oncotarget · 21
PDF
Abstract 4652: The autophagy-senescence connection in chemotherapy of breast tumor cells; senescence accelerated by autophagy but not dependent on autophagy
2012 · Rachel W. Goehe, Xu Di, et al. · Cancer Research · 14
The Use of a Stably Expressed FRET Biosensor for Determining the Potency of Cancer Drugs
2014 · William P. Bozza, Xu Di, et al. · PLoS ONE · 12
PDF
Stilbene 5c, a microtubule poison with vascular disrupting properties that induces multiple modes of growth arrest and cell death
2013 · M.R. Alotaibi, B. Asnake, et al. · Biochemical Pharmacology · 9
Abstract 2663: Dual cytoprotective and cytotoxic functions of autophagy in the response ofbreast tumor cells to radiation and in radiosensitization by vitamin D3
2011 · Molly L. Bristol, Xu Di, et al. · Cancer Research · 2
Data from FDA Approval Summary: Calaspargase Pegol-mknl For Treatment of Acute Lymphoblastic Leukemia in Children and Young Adults
2023 · Ruo-Jing Li, Runyan Jin, et al.
Supplementary Tables S1 and S2 from FDA Approval Summary: Calaspargase Pegol-mknl For Treatment of Acute Lymphoblastic Leukemia in Children and Young Adults
2023 · Ruo-Jing Li, Runyan Jin, et al.
PDF
Supplementary Tables S1 and S2 from FDA Approval Summary: Calaspargase Pegol-mknl For Treatment of Acute Lymphoblastic Leukemia in Children and Young Adults
2023 · Ruo-Jing Li, Runyan Jin, et al.
Data from FDA Approval Summary: Calaspargase Pegol-mknl For Treatment of Acute Lymphoblastic Leukemia in Children and Young Adults
2023 · Ruo-Jing Li, Runyan Jin, et al.
Works count: 37
Citation count: 1,569
H-index: 17
I10-index: 19
Year
Topic
Type